TY - JOUR
T1 - Parameter subset reduction for patient-specific modelling of arrhythmogenic cardiomyopathy-related mutation carriers in the CircAdapt model
T2 - Parameter Subset Reduction
AU - Van Osta, Nick
AU - Lyon, Aurore
AU - Kirkels, Feddo
AU - Koopsen, Tijmen
AU - Van Loon, Tim
AU - Cramer, Maarten J.
AU - Teske, Arco J.
AU - Delhaas, Tammo
AU - Huberts, Wouter
AU - Lumens, Joost
N1 - Funding Information:
Data accessibility. The source code supporting this article have been uploaded as part of the electronic supplementary material. Authors’ contributions. N.v.O. conceived the study, performed the simulations and wrote the first version of the manuscript. F.K., M.J.C. and A.J.T. provided the data. A.L., T.K., T.v.L., T.D., W.H. and J.L. helped with analysis and interpretation of the data. All co-authors critically read the paper and approved it. W.H. and J.L. contributed equally. Competing interests. We declare we have no competing interests. Funding. N.v.O., A.L. and J.L. were funded through the Netherlands Organisation for Scientific Research (NWO-ZonMw, VIDI grant no. 016.176.340 to J.L.). T.K. and J.L. were funded by the Dutch Heart Foundation (2015T082 to J.L.). F.K., T.v.L., M.J.C., T.D., A.J.T. and W.H. received no specific funding for this work. The funders had no role in study design or data.
Publisher Copyright:
© 2020 The Authors.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6/12
Y1 - 2020/6/12
N2 - Arrhythmogenic cardiomyopathy (AC) is an inherited cardiac disease, clinically characterized by life-threatening ventricular arrhythmias and progressive cardiac dysfunction. Patient-specific computational models could help understand the disease progression and may help in clinical decision-making. We propose an inverse modelling approach using the CircAdapt model to estimate patient-specific regional abnormalities in tissue properties in AC subjects. However, the number of parameters (n = 110) and their complex interactions make personalized parameter estimation challenging. The goal of this study is to develop a framework for parameter reduction and estimation combining Morris screening, quasi-Monte Carlo (qMC) simulations and particle swarm optimization (PSO). This framework identifies the best subset of tissue properties based on clinical measurements allowing patient-specific identification of right ventricular tissue abnormalities. We applied this framework on 15 AC genotype-positive subjects with varying degrees of myocardial disease. Cohort studies have shown that atypical regional right ventricular (RV) deformation patterns reveal an early-stage AC disease. The CircAdapt model of cardiovascular mechanics and haemodynamics has already demonstrated its ability to capture typical deformation patterns of AC subjects. We, therefore, use clinically measured cardiac deformation patterns to estimate model parameters describing myocardial disease substrates underlying these AC-related RV deformation abnormalities. Morris screening reduced the subset to 48 parameters. qMC and PSO further reduced the subset to a final selection of 16 parameters, including regional tissue contractility, passive stiffness, activation delay and wall reference area. This article is part of the theme issue 'Uncertainty quantification in cardiac and cardiovascular modelling and simulation'.
AB - Arrhythmogenic cardiomyopathy (AC) is an inherited cardiac disease, clinically characterized by life-threatening ventricular arrhythmias and progressive cardiac dysfunction. Patient-specific computational models could help understand the disease progression and may help in clinical decision-making. We propose an inverse modelling approach using the CircAdapt model to estimate patient-specific regional abnormalities in tissue properties in AC subjects. However, the number of parameters (n = 110) and their complex interactions make personalized parameter estimation challenging. The goal of this study is to develop a framework for parameter reduction and estimation combining Morris screening, quasi-Monte Carlo (qMC) simulations and particle swarm optimization (PSO). This framework identifies the best subset of tissue properties based on clinical measurements allowing patient-specific identification of right ventricular tissue abnormalities. We applied this framework on 15 AC genotype-positive subjects with varying degrees of myocardial disease. Cohort studies have shown that atypical regional right ventricular (RV) deformation patterns reveal an early-stage AC disease. The CircAdapt model of cardiovascular mechanics and haemodynamics has already demonstrated its ability to capture typical deformation patterns of AC subjects. We, therefore, use clinically measured cardiac deformation patterns to estimate model parameters describing myocardial disease substrates underlying these AC-related RV deformation abnormalities. Morris screening reduced the subset to 48 parameters. qMC and PSO further reduced the subset to a final selection of 16 parameters, including regional tissue contractility, passive stiffness, activation delay and wall reference area. This article is part of the theme issue 'Uncertainty quantification in cardiac and cardiovascular modelling and simulation'.
KW - arrhythmogenic cardiomyopathy
KW - CircAdapt
KW - Morris screening method
KW - parameter subset reduction
KW - particle swarm optimization
KW - quasi-Monte Carlo
UR - http://www.scopus.com/inward/record.url?scp=85085456496&partnerID=8YFLogxK
U2 - 10.1098/rsta.2019.0347
DO - 10.1098/rsta.2019.0347
M3 - Article
C2 - 32448061
AN - SCOPUS:85085456496
SN - 1364-503X
VL - 378
SP - 1
EP - 16
JO - Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
JF - Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
IS - 2173
M1 - 20190347
ER -